Literature DB >> 31662817

Erratum to "Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway".

Jinfan Tian1,2, Mohammad Sharif Popal1, Yanfei Liu3, Rui Gao4, Shuzheng Lyu1, Keji Chen2, Yue Liu2.   

Abstract

[This corrects the article DOI: 10.1155/2019/8134678.].
Copyright © 2019 Jinfan Tian et al.

Entities:  

Year:  2019        PMID: 31662817      PMCID: PMC6754939          DOI: 10.1155/2019/3084083

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN: 1942-0994            Impact factor:   6.543


In the article titled “Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway” [1], there was an error in the group labels of Figures 5(d) and 5(e), where the second and third group labels in each image were reversed. Additionally, there was an error in Figure 5(b) where the symbol “∗” should be corrected to “∗∗” in the Normal group bar. The corrected figure is shown below.
Figure 1

Effects of GBE on serum lipid and glucose profiles. ∗P < 0.05 and ∗∗P < 0.01, compared to the model group. GBE: ginkgo biloba leaf extract (normal group n = 18, model group n = 7, model control group n = 7, atorvastatin group n = 11, rapamycin group n = 15, 200 mg/kg/day GBE group n = 10, and 400 mg/kg/day GBE group n = 12).

  1 in total

1.  Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway.

Authors:  Jinfan Tian; Mohammad Sharif Popal; Yanfei Liu; Rui Gao; Shuzheng Lyu; Keji Chen; Yue Liu
Journal:  Oxid Med Cell Longev       Date:  2019-03-18       Impact factor: 6.543

  1 in total
  1 in total

Review 1.  ROS and Endoplasmic Reticulum Stress in Pulmonary Disease.

Authors:  Xiangning Cui; Yang Zhang; Yingdong Lu; Mi Xiang
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.